An industrial impulse

Embarking on an academic career means choosing university life over the corporate world. So why are many academics now turning their attention to commercial challenges?

Far from being an ivory tower, Imperial College London is highly engaged with the outside world. Its people collaborate intensively with colleagues from other organisations, and many work on devising and implementing practical solutions to real-world challenges.

This often involves engaging with the commercial world, for example by working with industry partners, or forming spinout companies. But what inspires academics and researchers, having consciously chosen to work in academia, to pivot to this more commercial kind of problem-solving? It turns out the motivations are quite varied.

Enriching research

For some academics, working on problems provided by industry collaborators helps positively shape their everyday research.

The plain vanilla problem you think of as a researcher can be boring – problems from industry come with different constraints.
Professor Ruth Misener

Professor Ruth Misener in the Department of Computing finds that working with organisations such as the global chemical company BASF has been a great source of problems that are more intellectually stimulating than those she comes up with on her own.

“In this area, the plain vanilla problem you think of as a researcher can be really boring,” she says. There’s also a danger that researchers think of the same thing at the same time, because it is the obvious next step. “If you’re getting problems from industry, you are still working in your area, but you have different constraints or mathematical formalism that makes you think: wait a minute, that changes everything! And you have to adjust.”

This does not mean agreeing uncritically to any collaboration opportunity. Professor Bernadette Byrne in the Department of Life Sciences specialises in understanding the mechanisms of living cells, including how protein-lipid interactions affect membrane protein function. Because of that expertise, pharmaceutical and biotech companies often approach her to work on proteins they find interesting, and such offers are carefully weighed up.

“You don’t want to dilute the effort of lab too much, but at the same time you always learn something from working with other people,” she says. “Sometimes it brings a refreshing aspect to what we are doing, and it also allows us to access their expertise and resources.”

Working with real-world cases also appeals to Dr Gbemi Oluleye, whose interest lies in market-based interventions for sustainability. Based in the Grantham Institute for Climate Change, she joins research partnerships led by Imperial colleagues if they need her expertise in economics and policy development, and carries out consultancy work through Imperial Consultants.

You don’t want to dilute the effort of lab too much, but at the same time you always learn something from working with other people.
Professor Bernadette Byrne

“My research provides an understanding of how market-based interventions create the economic signals to make low-carbon technologies economically viable,” she explains. “So, I spend a lot of time developing data-driven models, exploring assumptions about these technologies, and quantifying their economic viability under different market-based interventions across different parts of the world.”

These research models are quite broad, so consultancy projects provide an opportunity to apply the models to specific technologies in distinct market contexts, and to test them using real-world data. “This has helped me identify the key factors that improve the viability of low-carbon technology and alternative business models that could accelerate their deployment. In turn, those insights feed back into and strengthen my research.”

Enhancing the student experience

It is not just academics who benefit from contact with companies. It can also enrich student life. For example, Dr Oluleye likes to use her consultancy projects as case studies for teaching.

“Students are used to seeing hypothetical case studies, so they really enjoy discovering that my case studies are based on real projects,” she says . “When they see that a case study has been developed through engagement with companies such as ScottishPower, Schneider Electric, Aegis Energy or Skydiamond as they work towards greater sustainability, it changes the conversation. It’s not just an example case study for them.”

Students are used to seeing hypothetical case studies, so they really enjoy discovering that my case studies are based on real projects.
Dr Gbemi Oluleye

For Professor Misener, industry problems provide a chance to step back from the highly changeable area of machine learning and artificial intelligence. “Machine learning is a stressful place to be for students at the moment, because it moves so fast and there is always a risk of being overtaken,” she says. “That doesn’t really happen when you get these specific problems from industry. So, it gives me time and space to mentor the students properly as well.”

Contact with companies can also help students decide what their next steps might be. “So many of our PhD students are interested in careers in industry, and the opportunity to talk to someone who has been through that is really valuable,” says Professor Byrne. “So, sometimes I’ll ask our partners to do me a favour and come in to talk to our students.”

That effect is even greater for PhD students in her department who are funded by industry. “The student will act as a sort of conduit to the company,” Professor Byrne explains. “You are building connections, you are building your network, and that is useful for the student, but also incredibly useful for me as well.”

I studied engineering because I liked problem-solving, and a lot of students have the same motivation. Industrial research projects give you the opportunity to do that.
Professor Maria Charalambides

Professor Maria Charalambides in the Department of Mechanical Engineering also appreciates the benefits industrial collaboration can bring to PhD students. “I studied engineering because I liked problem-solving, and a lot of students have the same motivation,” she says. “Industrial research projects give you the opportunity to do that.”

Working with an industrial supervisor also exposes students to the different ways of working in industry and help them develop skills that can enhance their CVs. “Some industrial sponsors are very involved, and every three months want to have a meeting where the student presents what they have been doing, and what the problems and successes were,” she says. “You don’t get that kind or experience from working only in an academic environment.”

Other companies are more hands-off, particularly in rapidly changing industries. “But they are always a mentor to the student, so they have someone they can ask questions and get new ideas from, apart from their academic supervisors.”

Jumping on unexpected opportunities

Sometimes commercial applications arise unexpectedly, and academics get drawn in to areas of work they did not expect to be involved in.

Professor Byrne is used to providing insights to industrial partners, but only once has research from her lab resulted directly in a new product. The context was an EU scheme for PhD training that included a company placement for each student. Usually, the host company proposes a topic, but in the case of Molecular Dimensions, a company specialising in protein structure analysis tools, this was left to Professor Byrne and her student Cristina Cecchetti.

“Everyone is interested in knowing which membrane proteins are interacting with which membrane lipids, but it is not so easy to work out,” Professor Byrne recalls. “So, Cristina had the idea of developing a simple screen that people can use to do that.”

Dr Cecchetti, as she is now, worked on the screen while at Molecular Dimensions, and continued refining the method with Professor Byrne throughout her PhD. Once the results were published, the know-how was licensed to the company for commercialisation. The RAMP lipid screen was put on the market in 2025.

I thought: this might be the only time I ever do this, so I should go for it.
Professor Bernadette Byrne

Commercial potential is so rare in Professor Byrne’s basic research that she seized the opportunity to take it forward. “I thought: this might be the only time I ever do this, so I should go for it,” she says. An important consideration for this step outside her comfort zone was having the support of Dr Mei Chong, from Imperial Enterprise. “She convinced me it was do-able, and was with me every step of the way.”

That opportunity can also develop more gradually, as the result of seeing how business uses the results of research. For example, having validated her models with so many real-world examples, Dr Oluleye is now considering commercialising her work. “I’ve used the feedback from my consultancy projects to make my models more accessible, and over past year have created a dashboard that could potentially become an online tool,” she says.

Options for creating a spinout company based on this know-how are currently being explored with Imperial Enterprise and she has presented the dashboard to figures in industry and government as a customer discovery phase. “That would not have been possible without these consultancy projects, which gave me the confidence to do this on a larger scale.”

Following a plan

The process for Dr Max Munford has been a little different, since he embarked upon a PhD in the Department of Mechanical Engineering as a deliberate first step toward founding a medical technology company.

This was after a brief period working in two med tech firms following his undergraduate studies. “I really liked what was going on there,” he says. “It proved to me that I loved engineering for people, and I felt that could lead to greater impact than engineering for cars or planes.”

But could there be a route that offered greater challenge or opportunities during early-career? “While I loved working in those companies, I felt disconnected from the impact,” he says.

While he began his PhD without knowing which product his company would go on to develop, he had singled out medical 3D printing as a promising area. “I knew that I would be able to learn a lot about 3D printing for orthopaedics in the Mech Eng department, and very quickly build knowledge in that space.”

As a founding engineer, you will normally have skin in the game with a company and you will be connected to the impact of the work and learn a lot about yourself.
Dr Max Munford

After that, it was a case of moving from one milestone to another, from research to company development through Imperial’s entrepreneurial ecosystem. Dr Munford set up OSSTEC in 2021, and between 2023 and 2025 raised £4 million to take its system of next-generation bone implants into the operating room. During the next year he expects to see the first surgeries and regulatory approval for the US.

Starting a company is not for everyone, he says, but postdocs and even seasoned academics should consider getting involved with startups as a way of seeing their research have real impact and closing the feedback loop between users and their research. This could be as a science or engineering lead rather than as a CEO.

“As a founding engineer, you will normally have skin in the game with a company, and you will be connected to the impact of the work and learn a lot about yourself,” he says. “But you won’t have to take the same risk, or do the things you are not interested in, like building relationships with investors, working with commercial partners, or managing people. Lots of engineers want to remain in their technical domain rather than adopt the very different CEO-type role.”

Professor Jonathan Jeffers, the Associate Dean for Enterprise in the Engineering faculty, took a similar route and serves as OSSTEC’s chief technology officer.

Realising the value of research

In some disciplines, research only has an impact once it is adopted by industry. “Engineering is about making a difference to the world, and you can’t do that sitting in isolation in a university lab,” says Professor Nigel Brandon, Dean of the Faculty of Engineering. “You have to engage with the real world, and that means either engaging with companies or creating a company that then engages with companies. Without that, it’s just an idea.”

His first spinout sprang from work with colleagues in the Department of Materials on a new kind of fuel cell. They thought about licensing it to industry, but the technology was just too disruptive, so they set up their own company, Ceres Power. Twenty-six years later it is now listed on the London Stock Exchange, with a £1 billion market capitalisation. “It’s taken a long time, but now we are seeing our ideas translated into practice,” Professor Brandon says.

Engineering is about making a difference to the world, and you can’t do that sitting in isolation in a university lab. You have to engage with the real world.
Professor Nigel Brandon

Professor Brandon went on to create two further spinouts at the intersection of energy and materials. First RFC Power, which he co-founded with Professor Anthony Kucernak in the Department of Chemistry. And then M-Spin, which he co-founded with Dr Mengzheng Ouyang in the Department of Earth Science and Engineering. This is developing high-surface area materials that can significantly improve the performance and lower the cost of a wide range of electrochemical devices, as well as improving the thermal management of high-performance chips for AI applications.

In each case the process has been satisfying. “I enjoy that link between science, new ideas and the opportunity to build something innovative. That is intellectually stimulating and rewarding, and it is good for my team, for my students and postdocs.”

The challenge for an academic is to identify when their research has that commercial potential, and to understand enough about the market opportunity to know if their research will provide a breakthrough. “At Imperial, we’ve created an ecosystem that provides support for that journey, something we are continually working to strengthen.”

Realising the value of research can also involve giving something back to fellow scientists. In the case of Professor Byrne's protein interaction screen, she was convinced the cell biology community would benefit. “I genuinely thought people might find this useful, that it would streamline and speed up identifying these specific protein-lipid interactions,” she says.

Solving a problem close to your heart

The motivation for translating research into a product or service can also be personal. For Dr Amanda Sathyapala, an associate professor in the National Heart and Lung Institute and consultant respiratory physician at Guys and St Thomas' NHS Foundation Trust, it was seeing her sleep apnoea patients miss out on treatment.

The health risks of obstructive sleep apnoea, in which patients have brief pauses in breathing during sleep, can be managed effectively if they wear a continuous positive airway pressure (CPAP) machine while they sleep. The problem is that many don’t stick with it.

"We’re churning out CPAP machines, but patients aren’t being supported in the right way to use them, and as a result are still having heart attacks and strokes as consequences of the condition,” Dr Sathyapala says. So, she and her team are developing a smartphone app called CPAP Buddy, which will provide patients with videos and activities designed to motivate them and support their use of CPAP machines.

Although all science is creative, inventing and developing a new medical device is my most innovative work to date.
Dr Amanda Sathyapala

“Although all science is creative, inventing and developing a new medical device is my most innovative work to date, because the potential is down to me and not limited by anyone else,” she says. “This has been exhilarating. It has also meant working with some of the most creative people I have met, who are not academics but extremely talented graphic designers and software engineers, for example, to push boundaries to produce the best product for patients and also increase the level of innovation to my other work.”

She is also working in partnership with Fisher & Paykel Healthcare, a leading global manufacturer of CPAP masks and devices, which has provided further funding and its experience with the treatment. “Our large commercial partner is important in supporting us in terms of decisions regarding the route to market, so we achieve real-world, large-scale patient benefit as quickly as possible.”

For another academic innovator, Dr Mohammad Redwanur Rahman, who studied fisheries and aquaculture in Bangladesh, the motivation was seeing the pollution caused by chemical dyes escaping from the textile industry. Closing these economically essential businesses is not an option, so he started to think about sustainable alternatives.

This led him to a PhD in Imperial's Department of Chemical Engineering, where he worked on replacement dyes and pigments that could be extracted from algae, natural biomaterials whose production would be straightforward to scale up, and with other environmental benefits.

I started this, I know how it works and if I take it forward there will be an opportunity to do something meaningful for people back home.
Dr Mohammad Redwanur Rahman

At the end of his PhD, patents were filed on a low energy dye extraction process and on a method for sustainably fixing those dyes in textiles. This was as far as the technology could go in the academic setting, so he decided to create a spinout company, Brilliant Dyes. “I was too much into the idea to let it go, and I started believing strongly that our solutions have the potential to solve massive global problems across textile, cosmetics and foods industries,” Dr Rahman says.

This gave him the confidence to take the company forward. “I started this, I know how it works and if I take it forward there will be an opportunity to do something meaningful for people back home,” he says. “That’s both in terms of reducing pollution to improve our people’s health but also helping them prepare for the trade restrictions on synthetic dyes that are likely to come from Europe.”

Being co-founder and chief executive of Brilliant Dyes has been a rewarding experience. “It’s still problem-solving, but more elements are involved, “ Dr Rahman says. “It’s not just research, but team development, securing grants and investments, scaling the solution, securing customers and developing long-term partnerships.”

A sense of strong professional growth is a further benefit, and the potential for a long-term financial return if the company is successful. But for that to happen, it must address many challenges. “Having the awards and grants from reputed bodies can be a motivation, but it works the other way as well,” he says. “People usually don’t understand that for the first one or two years an entrepreneur might be working long hours without any salary, handling many uncertainties, sacrifices and pressures, so you need to think about both sides.”

Professor Brandon agrees that making money from entrepreneurship cannot be taken for granted. “There can be financial benefits, and done in the right way creating a spinout can enhance your academic reputation,” he says. “But all of these things come with success, and you have to remember that most spinouts will not achieve success. But even if it doesn’t work commercially, you will still learn a lot.”

Imperial staff can learn about support available to turn research into industry impact on the Imperial Enterprise web pages.